Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits


escrs app advert yo advert

Cataract surgery combined with 0,7mg intravitreal dexamethasone implant in diabetic patients with pre-existent macular edema: our experience

Search Title by author or title

Session Details

Session Title: Combined Cataract Surgery: Techniques/Practice Styles

Session Date/Time: Tuesday 13/09/2016 | 14:00-16:00

Paper Time: 14:30

Venue: Auditorium C6

First Author: : G.Addabbo ITALY

Co Author(s): :    F. Pignatelli   F. Prima                 

Abstract Details


To retrospectively study the efficacy of a single 0.7mg dexamethasone intravitreal implant simultaneously phacoemulsification and IOL implant in diabetic patients with pre-existent macular edema


Department of ophtalmology, St J. Moscati Hospital, Taranto, Italy.


78 eyes of 54 patients with diabetic macular edema and cataract were retrospectivly reviewed. 40 eyes (group A) underwent standard cataract surgery while 38 eyes (group B) underwent cataract surgery and intravitreal injection of 0.7-mg dexamethasone implant at the same time. All surgeries were performed by the same surgeon, phacoemulsification with IOL implant was the technique of choise. Best-corrected visual acuity (BCVA), central retinal thickness (CRT) intraocular pressure (IOP) was evaluated at baseline, 1 month and 6 motnhs.


After a mean follow-up of 6 months, in gruop A mean BCVA increased from 0,53 logmar to 0,44 logmar (P= 0,1) , mean CRT increased from 264 µm to 337µm (P= 0,005), whie IOP did not change significantly. In gruop B mean BCVA was signicantly increased from 0,58 logmar to 0,20 logmar (P< 0,00001) , mean CRT decreased from 305,19 µm to 224,24 µm (P= 0,05), whie IOP did not change significantly. Mean BVCA in group B compared to group A was significantly better (0,20 logmar vs 0,44logmar P<0,0001) and mean CRT was significantly lower ( 224,24 µm to 337,23 µm P=0,001). No postoperatives complications were observed.


Our results strongly suggest that a single injection of 0.7 mg dexamethasone intravitreal implant combined with phacoemuslification and IOL implant is a safe and effective approach for those patient with cataract and diabetic maculare edema.

Financial Disclosure:


Back to previous